Chronic obstructive pulmonary disease is the fourth leading cause of death worldwide and further increases are anticipated. An estimated 300 million people suffer from asthma.
More information about our products is available by clicking on the names below.
|Brand name||Generic name|
|Accolate, Accoleit, Vanticon||zafirlukast|
|Delivery devices for AstraZeneca products|
Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.